Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

256.90 +1.43 (+0.56%)

Streaming Delayed Price Updated: 11:54 AM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

April 23, 2025

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with...

Via StockStory

Topics Artificial Intelligence

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

April 23, 2025

From Resmed, Inc.

Via GlobeNewswire

A Look Ahead: ResMed's Earnings Forecast ↗

April 22, 2025

Via Benzinga

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

April 22, 2025

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

Beyond The Numbers: 6 Analysts Discuss ResMed Stock ↗

March 05, 2025

Via Benzinga

Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday? ↗

April 23, 2025

Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.

Via Benzinga

Topics Government

Earnings Scheduled For April 23, 2025 ↗

April 23, 2025

Via Benzinga

Resmed Names Salli Schwartz as Chief Investor Relations Officer

April 21, 2025

Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community

From Resmed, Inc.

Via GlobeNewswire

Assessing ResMed: Insights From 5 Financial Analysts ↗

April 21, 2025

Via Benzinga

Why RESMED INC (NYSE:RMD) is a Top Pick for Dividend Investors. ↗

April 15, 2025

Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD).

Via Chartmill

Which S&P500 stocks are gapping on Tuesday? ↗

April 08, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

April 08, 2025

Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

April 03, 2025

FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosis

From Resmed, Inc.

Via GlobeNewswire

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

April 03, 2025

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

Via StockStory

Topics Artificial Intelligence

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

April 02, 2025

From Resmed, Inc.

Via GlobeNewswire

Why RESMED INC (NYSE:RMD) Deserves Consideration as a Quality Investment. ↗

April 01, 2025

A fundamental analysis of (NYSE:RMD): Is RESMED INC (NYSE:RMD) suited for quality investing?

Via Chartmill

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

March 21, 2025

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

March 19, 2025

Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of...

From Resmed, Inc.

Via GlobeNewswire

Tempted To Dump Stock? Consider Shifting To Low Vol Stocks / ETFs Instead ↗

March 16, 2025

While plummeting stock indexes sent some investors screaming for the exits, others look to shift assets from large-cap tech stocks and cap-weighted ETFs into less volatile investments..

Via Talk Markets

Topics ETFs Stocks / Equities

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

March 11, 2025

Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone

From Resmed, Inc.

Via GlobeNewswire

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

March 11, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...

Via StockStory

Topics Artificial Intelligence

Top S&P500 movers in Monday's session ↗

March 10, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗

March 10, 2025

A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?

Via Investor's Business Daily

Exploring the top movers within the S&P500 index during today's session. ↗

March 05, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Discover which S&P500 stocks are making waves on Wednesday. ↗

March 05, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Gapping S&P500 stocks in Wednesday's session ↗

March 05, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends.

Via Chartmill

2 Reasons to Like RMD and 1 to Stay Skeptical

March 04, 2025

Since September 2024, ResMed has been in a holding pattern, posting a small loss of 4.8% while floating around $233.10. The stock also fell short of the S&P 500’s 6.2% gain during that period.

Via StockStory

Topics Stocks

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

February 27, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...

Via StockStory

Topics Artificial Intelligence

Here's How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today ↗

February 26, 2025

Via Benzinga

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

February 26, 2025

New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships

From ResMed Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.